Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children
JM Kemmeren, SS Timmer, NAT van der Maas… - Vaccine, 2011 - Elsevier
Background In 2005, an acellular pertussis-containing DTP-IPV-Hib vaccine for infants
replaced the whole-cell combination vaccine in the National Immunisation Programme of the …
replaced the whole-cell combination vaccine in the National Immunisation Programme of the …
Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in …
S David, PE Vermeer-de Bondt, NAT van der Maas - Vaccine, 2008 - Elsevier
BACKGROUND: In addition to the routine enhanced passive safety surveillance of the Dutch
National Vaccination Programme, RIVM (National Institute for Public Health and the …
National Vaccination Programme, RIVM (National Institute for Public Health and the …
Safety and efficacy of acellular pertussis vaccines: the Mainz study and other recent studies.
JA Weigl, HL Bock, R Clemens, F Zepp… - Annals of the …, 1997 - europepmc.org
Following concerns about the safety and reactogenicity profile of diphtheria, tetanus and
whole cell pertussis vaccines (DTwP), new and less reactogenic alternatives were …
whole cell pertussis vaccines (DTwP), new and less reactogenic alternatives were …
Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination
M Prelog, G Almanzar, N Rieber, B Ottensmeier… - Vaccine, 2013 - Elsevier
Compared to whole cell pertussis (wcP) vaccines, acellular pertussis vaccines (aP) have a
better safety profile with lower reactogenicity, although their short and long-term efficacy was …
better safety profile with lower reactogenicity, although their short and long-term efficacy was …
Reactogenicity of acellular pertussis vaccine in 4-year-olds in The Netherlands
MG Keijzer-Veen, L Holty-van der Wekken… - Vaccine, 2004 - Elsevier
Aim: To observe reactogenicity of a three-component acellular pertussis (aP) vaccine
simultaneously given with dT-IPV vaccine at the age of 4 years. Results: Of 813 subjects …
simultaneously given with dT-IPV vaccine at the age of 4 years. Results: Of 813 subjects …
Duration of protection after first dose of acellular pertussis vaccine in infants
HE Quinn, TL Snelling, KK Macartney… - Pediatrics, 2014 - publications.aap.org
OBJECTIVE: Data on the effectiveness of the diphtheria–tetanus–acellular pertussis (DTaP)
vaccine in the first 4 years of life are sparse. We evaluated the vaccine effectiveness (VE) of …
vaccine in the first 4 years of life are sparse. We evaluated the vaccine effectiveness (VE) of …
Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four-to six-year-old children
ME Pichichero, KM Edwards, EL Anderson… - …, 2000 - publications.aap.org
Objective. To evaluate the safety and immunogenicity of 6 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …
[引用][C] Acellular pertussis vaccines: the final countdown
HJ Schmitt - European journal of pediatrics, 1996 - Springer
" A great day for kids" said Dr. John La Montagne, director of the American National Institute
for Allergy and Infectious Diseases, Division of Microbiology and Infectious Diseases, when …
for Allergy and Infectious Diseases, Division of Microbiology and Infectious Diseases, when …
Two consecutive randomized controlled pertussis booster trials in children initially vaccinated in infancy with an acellular vaccine: The first with a five-component Tdap …
RM Carlsson, L Gustafsson, HO Hallander… - Vaccine, 2015 - Elsevier
Prior study children from a DTaP efficacy trial were recruited at ages 5 and 15 years to
randomized booster trials addressing immunogenicity and reactogenicity; 475 preschool …
randomized booster trials addressing immunogenicity and reactogenicity; 475 preschool …
Acellular pertussis vaccine safety and efficacy in children, adolescents and adults
JR Casey, ME Pichichero - Drugs, 2005 - Springer
This review offers a perspective on the acellular pertussis vaccine efficiency trials concluded
in the 1990s and presents the main conclusions of a meta-analysis of 52 studies that …
in the 1990s and presents the main conclusions of a meta-analysis of 52 studies that …